File:1-s2.0-S0264410X21009075-main.pdf

Revision as of 01:55, 7 February 2026 by Nhmkerala (talk | contribs) (Source PDF for: A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
1-s2.0-S0264410X21009075-main.pdf (0 × 0 pixels, file size: 4.39 MB, MIME type: application/pdf)

Source PDF for: A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeDimensionsUserComment
current01:55, 7 February 20260 × 0 (4.39 MB)Nhmkerala (talk | contribs)Source PDF for: A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses